Alder BioPharmaceuticals, Inc. EBITDA 2014-2019 | ALDR
Alder BioPharmaceuticals, Inc. ebitda from 2014 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Alder BioPharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2018 | $-284 |
| 2017 | $-288 |
| 2016 | $-156 |
| 2015 | $-86 |
| 2014 | $10 |
| 2013 | $-20 |
| 2012 | $-17 |
| Alder BioPharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2019-06-30 | $-55 |
| 2019-03-31 | $-114 |
| 2018-12-31 | $-77 |
| 2018-09-30 | $-58 |
| 2018-06-30 | $-64 |
| 2018-03-31 | $-85 |
| 2017-12-31 | $-54 |
| 2017-09-30 | $-60 |
| 2017-06-30 | $-74 |
| 2017-03-31 | $-100 |
| 2016-12-31 | $-49 |
| 2016-09-30 | $-35 |
| 2016-06-30 | $-39 |
| 2016-03-31 | $-33 |
| 2015-12-31 | $-26 |
| 2015-09-30 | $-27 |
| 2015-06-30 | $-18 |
| 2015-03-31 | $-15 |
| 2014-12-31 | $-7 |
| 2014-09-30 | $29 |
| 2014-06-30 | $-7 |
| 2014-03-31 | $-5 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-5 |
| 2013-03-31 | $-5 |
